Clinical trial
Evaluation and Treatment Strategy Development of Coronary Heart Disease Guided by Optical Coherence Tomography Based on Multimodal Deep Learning
NCT06544681 is registered in ClinicalTrials.gov with Xiang Ma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation and Treatment Strategy Development of Coronary Heart Disease Guided by Optical Coherence Tomography Based on Multimodal Deep Learning
- Lead sponsor
- Xiang Ma
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- August 20, 2024
- Completion date
- December 31, 2026
- Enrollment
- 2,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.